Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multicenter, Open-Label Study To Evaluate the Efficacy and Safety of GAMMAPLEX® in Chronic Idiopathic Thrombocytopenic Purpura

NCT00504075 is registered in ClinicalTrials.gov with Bio Products Laboratory as lead sponsor.

NCT NCT00504075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00504075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multicenter, Open-Label Study To Evaluate the Efficacy and Safety of GAMMAPLEX® in Chronic Idiopathic Thrombocytopenic Purpura
Lead sponsor
Bio Products Laboratory
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2007
Completion date
August 31, 2011
Enrollment
35 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

chronic idiopathic thrombocytopenic purpura